ADVERTISEMENT
search.svg

Pharmacy News

APhA House of Delegates debates health inequities, harassment, national pharmacy organization unity

At its Monday, March 15, 2021 business session, members of the APhA House of Delegates (HOD) considered policies salient to both pharmacy and the nation at large, including abuse of power and harassment in the profession, anti-racism, and social determinants of health. The session also included discussion on medications for opioid-use disorder and a proposal to unify national pharmacy organizations.

APhA2021 Virtual honors this year’s Immunization Champions

The 13th Annual APhA Immunization Champions Award Ceremony, held on Sunday, March 14, recognized the innovative pharmacists, practices, and community leaders who protect patients and the community from vaccine-preventable diseases.

U.S. government scientists skeptical of one-shot regimen for Pfizer, Moderna COVID vaccines

U.S. health experts say they cannot get behind proposals to switch to single-dose regimens of the Pfizer and Moderna coronavirus vaccines, which were approved under a two-dose protocol. Seven U.S.

Update to asthma guidelines covers ICS, LAMAs, indoor allergy mitigation, more

In December 2020, the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee released a focused update to its 2007 asthma guidelines. The update covers select topics, such as intermittent use of inhaled corticosteroids (ICS), the role of long-acting muscarinic antagonists (LAMAs), indoor allergy mitigation, use of immunotherapy, bronchial thermoplasty, and fractional exhaled nitric oxide (FeNO) testing. 

One and done: Why people are eager for Johnson & Johnson's vaccine

Many Americans have expressed a preference for Johnson & Johnson's coronavirus vaccine, even though its 72% efficacy rate lags that of the Pfizer and Moderna vaccines, which are about 95% effective. For recipients, the convenience of a single-dose is worth forfeiting the extra cushion of protection.

RSS
124678910Last